Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HLFHERBALIFE LTD.

NYSE · CIK 0001180262
Filer categoryLarge accelerated filer
Entity typeoperating
SIC5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
FY end1231
XBRL facts487

Identity from submissions API

NameHERBALIFE LTD.
CIK0001180262
TickersHLF
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone310 410 9600
Website—
Investor website—
Owner org07 Trade & Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • HERBALIFE NUTRITION LTD. (2018-04-27T00:00:00.000Z → 2023-04-11T00:00:00.000Z)
  • WH HOLDINGS CAYMAN ISLANDS LTD (2002-08-12T00:00:00.000Z → 2004-12-13T00:00:00.000Z)
Business address
P.O. BOX 309GT
UGLAND HOUSE, SOUTH CHURCH STREET
GEORGE TOWN
E9
00000
Cayman Islands
Mailing address
P.O. BOX 309GT
UGLAND HOUSE, SOUTH CHURCH STREET
GEORGE TOWN
E9
00000
Cayman Islands

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

2391 filing rows loaded from submissions recent; extra archives: CIK0001180262-submissions-001.json (1384 filings, 2002-08-12 to 2015-02-11).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001061768-26-000014 005-80216 261551024 34 11980
2026-11-06 4 xslF345X06/ownership.xml 0001213900-26-116950 6074
2026-11-06 4 xslF345X06/ownership.xml 0001213900-26-116948 6124
2026-11-06 3 xslF345X06/ownership.xml 0001213900-26-116943 16523
2026-11-02 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-114951 001-32381 261512678 34 639217 1 1
2026-11-02 10-Q 10-Q 0001193125-26-443675 001-32381 261512539 34 18469297 1 1
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001627 005-80216 261505973 34 7907
2026-08-31 8-K CURRENT REPORT 5.02 0001213900-26-095328 001-32381 261342460 34 186791 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000052 005-80216 261273842 34 9863
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002022 005-80216 261247058 34 11939
2026-08-05 4 OWNERSHIP DOCUMENT 0001213900-26-085703 5365
2026-08-05 8-K CURRENT REPORT 2.02,5.02,7.01,9.01 0001213900-26-085702 001-32381 261243998 34 677766 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335172 001-32381 261243838 34 17377086 1 1
2026-06-04 4 xslF345X06/ownership.xml 0001213900-26-065417 5019
2026-05-20 4 xslF345X06/ownership.xml 0001213900-26-059762 17937
2026-05-20 3/A xslF345X06/ownership.xml 0001213900-26-059761 14521
2026-05-19 144 xsl144X01/primary_doc.xml 0001921094-26-000521 001-32381 26999927 33 5224
2026-05-18 144 xsl144X01/primary_doc.xml 0001921094-26-000513 001-32381 26993922 33 4746
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062714 005-80216 26989050 34 11274
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055398 7052
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055397 5368
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055396 5547
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055395 5375
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055394 5396
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055393 5402
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055392 6096
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055391 5390
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055389 6158
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055388 5392
2026-05-12 4 xslF345X06/ownership.xml 0001213900-26-055386 5415
2026-05-12 3 xslF345X06/ownership.xml 0001213900-26-055385 4766
2026-05-12 3/A xslF345X06/ownership.xml 0001213900-26-055383 4446
2026-05-12 144 xsl144X01/primary_doc.xml 0001957799-26-000070 001-32381 26969511 33 5340
2026-05-11 144 xsl144X01/primary_doc.xml 0001921094-26-000454 001-32381 26963345 33 5136
2026-05-06 8-K CURRENT REPORT 2.02,5.07,7.01,9.01 0001213900-26-052833 001-32381 26948956 34 587391 1 1
2026-05-06 10-Q 10-Q 0001193125-26-209074 001-32381 26948858 34 14489533 1 1
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001200 005-80216 26946747 34 11450
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052504 7776
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052503 5378
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052501 7070
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052500 7323
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052499 7095
2026-05-05 4 OWNERSHIP DOCUMENT 0001213900-26-052498 7097
2026-05-01 8-K CURRENT REPORT 1.01,2.03,2.04,8.01,9.01 0001213900-26-051010 001-32381 26933576 34 4283294 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000145 005-80216 26912471 34 7726
2026-04-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000034 005-80216 26905440 34 7774
2026-04-16 8-K CURRENT REPORT 8.01,9.01 0001213900-26-044204 001-32381 26865309 34 233356 1 1
2026-04-14 8-K CURRENT REPORT 2.02,8.01,9.01 0001213900-26-043269 001-32381 26859413 34 307205 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000418 005-80216 26795321 34 7546
2026-03-17 ARS ARS 0001213900-26-029139 001-32381 26762696 34 2308571
2026-03-17 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-029134 001-32381 26762621 34 4365057
2026-03-17 DEF 14A PROXY STATEMENT 0001213900-26-029131 001-32381 26762547 34 29107838 1 1
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023337 6230
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023336 6246
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023335 8119
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023334 6223
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023333 6241
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023332 6221
2026-03-03 4/A xslF345X05/ownership.xml 0001213900-26-023331 6263
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021912 5918
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021911 5923
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021910 7796
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021908 5898
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021907 5940
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021906 5907
2026-02-27 4 xslF345X05/ownership.xml 0001213900-26-021905 5900
2026-02-18 4 xslF345X05/ownership.xml 0001213900-26-017970 5219
2026-02-18 4 xslF345X05/ownership.xml 0001213900-26-017968 5190
2026-02-18 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-017966 001-32381 26648955 34 521717 1 1
2026-02-18 10-K 10-K 0001193125-26-057113 001-32381 26648676 34 27266133 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015332 005-80216 26634362 34 11226
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001037389-26-000012 005-80216 26625344 34 9765
2025-12-01 4 xslF345X05/ownership.xml 0001213900-25-116887 6359
2025-11-20 4 xslF345X05/ownership.xml 0001213900-25-113259 5320
2025-11-18 4 xslF345X05/ownership.xml 0001213900-25-112270 5928
2025-11-12 3 xslF345X02/ownership.xml 0001213900-25-109423 22366
2025-11-05 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-106671 001-32381 251454492 34 584963 1 1
2025-11-05 10-Q 10-Q 0001193125-25-267001 001-32381 251454319 34 17795889 1 1
2025-11-04 4 xslF345X05/ownership.xml 0001213900-25-106360 5214
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000627 005-80216 251377887 34 29501
2025-09-03 4 xslF345X05/ownership.xml 0001213900-25-084204 5219
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078721 005-80216 251220329 34 11168
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000500 005-80216 251213360 34 25066
2025-08-06 S-8 REGISTRATION STATEMENT 0001213900-25-072587 333-289311 251190308 33 267416 1 1
2025-08-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-072568 001-32381 251190063 34 506449 1 1
2025-08-06 10-Q 10-Q 0000950170-25-104051 001-32381 251189763 34 17427456 1 1
2025-06-16 8-K CURRENT REPORT 8.01 0001213900-25-054756 001-32381 251049959 34 187213 1 1
2025-06-10 144 xsl144X01/primary_doc.xml 0001921094-25-000647 001-32381 251038047 33 10166
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052736 4891
2025-05-23 4 xslF345X05/ownership.xml 0001213900-25-047329 4890
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049504 005-80216 25954184 34 11087
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001344676-25-000024 005-80216 25950544 34 10631
2025-05-12 3 xslF345X02/ownership.xml 0001213900-25-042200 20810
2025-05-12 3 OWNERSHIP DOCUMENT 0001213900-25-042198 19034
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040352 6904
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040344 5208
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040343 6905
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040341 6900
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040337 5231
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040333 5278
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040328 6021
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040325 5238
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040323 5263
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040320 5259
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040318 5253
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040316 6744
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040314 5251
2025-05-06 4 xslF345X05/ownership.xml 0001213900-25-040309 5255
2025-05-05 3 xslF345X02/ownership.xml 0001213900-25-039828 12441
2025-04-30 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-037675 001-32381 25896144 34 564537 1 1
2025-04-30 10-Q 10-Q 0000950170-25-061076 001-32381 25895563 34 13192729 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000562 005-80216 25892133 34 6597
2025-04-25 8-K CURRENT REPORT 5.07 0001213900-25-035657 001-32381 25875205 34 214397 1 1
2025-03-11 ARS ANNUAL REPORT 0001213900-25-022834 001-32381 25728896 34 3023146
2025-03-11 DEFA14A ADDITIONAL MATERIALS 0001213900-25-022832 001-32381 25728869 34 4335645
2025-03-11 DEF 14A PROXY STATEMENT 0001213900-25-022830 001-32381 25728852 34 29631746 1 1
2025-03-06 4 4 0000950170-25-034901 4679
2025-03-03 4 4 0000950170-25-031077 4682
2025-02-25 4 4 0000950170-25-027149 5018
2025-02-25 4 4 0000950170-25-027140 5023
2025-02-25 4 4 0000950170-25-027131 7412
2025-02-25 4 4 0000950170-25-027124 7638
2025-02-25 4 4 0000950170-25-027115 5760
2025-02-25 4 4 0000950170-25-027109 5875
2025-02-19 4 4 0000950170-25-023292 5024
2025-02-19 4 4 0000950170-25-023283 5039
2025-02-19 4 4 0000950170-25-023271 5066
2025-02-19 8-K CURRENT REPORT 2.02,5.02,7.01,9.01 0001213900-25-015314 001-32381 25640649 34 866368 1 1
2025-02-19 10-K 10-K 0000950170-25-023207 001-32381 25640420 34 24686832 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-002817 005-80216 25627919 34 11159
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-004309 005-80216 25620516 34 11185
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000136 005-80216 25619291 34 30115
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001037389-25-000013 005-80216 25617741 34 9773
2025-02-12 8-K CURRENT REPORT 5.02 0001213900-25-012882 001-32381 25614762 34 203096 1 1
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001019056-25-000061 005-80216 25594735 34 14590
2025-01-30 8-K CURRENT REPORT 8.01 0001213900-25-008428 001-32381 25574613 34 197429 1 1
2024-12-26 4 4 0000950170-24-140441 5067
2024-12-11 4 4 0000950170-24-135464 5248
2024-11-14 SC 13G/A AMENDMENT NO. 2 0001214659-24-019182 005-80216 241462255 34 69591
2024-11-13 4 4 0000950170-24-126431 5145
2024-11-13 SC 13G SC 13G 0001140361-24-046445 005-80216 241453863 34 121745
2024-11-13 SC 13G/A herbalife13ga3.htm 0000935836-24-000653 005-80216 241452719 34 91265
2024-11-07 SC 13G/A MS AMENDMENT 0000895421-24-000559 005-80216 241434429 34 18276
2024-11-05 4 4 0000950170-24-121696 6047
2024-11-05 4 4 0000950170-24-121688 5040
2024-10-30 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-24-092256 001-32381 241410615 34 782613 1 1
2024-10-30 10-Q 10-Q 0000950170-24-119016 001-32381 241410606 34 14249235 1 1
2024-10-30 8-K/A AMENDMENT NO. 1 TO FORM 8-K 5.02 0001213900-24-092235 001-32381 241410219 34 204902 1 1
2024-09-09 4 4 0000950170-24-104842 5146
2024-08-27 4 4 0000950170-24-101120 4684
2024-08-14 4 4 0000950170-24-097090 5146
2024-08-06 4 4 0000950170-24-092001 5014
2024-07-31 10-Q 10-Q 0000950170-24-088605 001-32381 241162251 34 13872148 1 1
2024-07-31 8-K 8-K 2.02,7.01,9.01 0001193125-24-189942 001-32381 241162233 34 543540 1 1
2024-07-08 3 3 0000950170-24-082113 16027
2024-06-26 8-K 8-K 5.02 0001193125-24-169026 001-32381 241073391 34 145462 1 1
2024-06-10 3 3 0000950170-24-071369 19569
2024-05-10 4 4 0000950170-24-057907 8310
2024-05-08 4 4 0000950170-24-055980 6047
2024-05-07 4 4 0000950170-24-054918 5027
2024-05-07 4 4 0000950170-24-054883 9293
2024-05-07 4 4 0000950170-24-054879 5023
2024-05-07 4 4 0000950170-24-054876 5036
2024-05-07 4 4 0000950170-24-054873 5025
2024-05-07 4 4 0000950170-24-054870 5084
2024-05-07 4 4 0000950170-24-054866 5055
2024-05-07 4 4 0000950170-24-054859 9411
2024-05-07 4 4 0000950170-24-054855 9080
2024-05-07 4 4 0000950170-24-054845 6700
2024-05-07 4 4 0000950170-24-054836 7479
2024-05-07 4 4 0000950170-24-054831 5030
2024-05-07 4 4 0000950170-24-054825 5010
2024-05-06 4 4 0000950170-24-053404 6592
2024-05-01 S-8 S-8 0001193125-24-127614 333-279047 24904000 33 82613
2024-05-01 8-K 8-K 2.02,5.07,7.01,9.01 0001193125-24-127561 001-32381 24903673 34 440650 1 1
2024-05-01 10-Q 10-Q 0000950170-24-051335 001-32381 24903644 34 12583632 1 1
2024-04-18 8-K 8-K 1.01,2.03,2.04,8.01,9.01 0001193125-24-100782 001-32381 24854371 34 3556654 1 1
2024-04-08 8-K 8-K 8.01,9.01 0001193125-24-088825 001-32381 24827974 34 187976 1 1
2024-04-01 8-K 8-K 8.01,9.01 0001193125-24-082701 001-32381 24805598 34 190397 1 1
2024-04-01 8-K 8-K 5.02 0001193125-24-082581 001-32381 24805397 34 144630 1 1
2024-03-28 8-K/A 8-K/A 5.02,9.01 0001193125-24-080572 001-32381 24798748 34 152336 1 1
2024-03-27 4 4 0000950170-24-037453 4992
2024-03-27 4 4 0000950170-24-037450 5144
2024-03-27 4 4 0000950170-24-037448 4670
2024-03-27 4 4 0000950170-24-037446 4675
2024-03-27 4 4 0000950170-24-037443 5726
2024-03-27 3 3 0000950170-24-037440 20563
2024-03-20 8-K 8-K 2.05,5.02,7.01,9.01 0001193125-24-072046 001-32381 24766268 34 221337 1 1
2024-03-13 4 4 0000950170-24-030884 5132
2024-03-12 ARS ARS 0001193125-24-065934 001-32381 24742663 34 1418123
2024-03-12 DEFA14A DEFA14A 0001193125-24-065931 001-32381 24742605 34 569644
2024-03-12 DEF 14A DEF 14A 0001193125-24-065924 001-32381 24742527 34 9264357 1 1
2024-03-12 4 4 0000950170-24-029965 6937
2024-03-11 3 3 0000950170-24-029353 16040
2024-03-07 8-K 8-K 5.02 0001193125-24-061556 001-32381 24728340 34 150129 1 1
2024-03-05 4 4 0000950170-24-026296 5094
2024-02-27 4 4 0000950170-24-021358 5071
2024-02-27 4 4 0000950170-24-021345 5178
2024-02-27 4 4 0000950170-24-021323 5095
2024-02-27 4 4 0000950170-24-021313 5075
2024-02-27 4 4 0000950170-24-021301 5098
2024-02-21 4 4 0000950170-24-018223 5072
2024-02-21 4 4 0000950170-24-018219 5076
2024-02-21 4 4 0000950170-24-018209 5179
2024-02-21 4 4 0000950170-24-018205 5098
2024-02-21 4 4 0000950170-24-018202 5095
2024-02-21 4 4 0000950170-24-018193 7513
2024-02-21 4 4 0000950170-24-018170 12923
2024-02-14 SC 13G/A herbalife13ga2.htm 0000935836-24-000212 005-80216 24640981 34 90427
2024-02-14 8-K HERBALIFE LTD. 8-K 2.02,7.01,8.01,9.01 0001157523-24-000245 001-32381 24639300 34 900939 1 1
2024-02-14 10-K 10-K 0000950170-24-015266 001-32381 24639031 34 20459317 1 1
2024-02-14 SC 13G/A AMEMDMENT NO. 1 0001214659-24-002844 005-80216 24637281 34 69558
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021109 005-80216 24628541 34 13399
2024-02-13 SC 13G/A kyg4412g1010_021324.txt 0001086364-24-006992 005-80216 24624289 34 14007
2024-02-13 SC 13G/A hlf-13g_20231231.txt 0001037389-24-000039 005-80216 24623424 34 13771
2024-02-09 4 4 0000950170-24-013429 6793
2024-02-09 4 4 0000950170-24-013418 6996
2024-02-09 4 4 0000950170-24-013413 6814
2024-02-08 SC 13G/A MS AMENDMENT 0000895421-24-000070 005-80216 24608552 34 17941
2024-01-10 3 FORM 3 SUBMISSION 0001209191-24-001361 6862
2024-01-09 8-K 8-K 5.02 0001193125-24-005296 001-32381 24524133 34 143858 1 1
2024-01-02 8-K 8-K 5.02,9.01 0001193125-24-000719 001-32381 24502991 34 168240 1 1
2023-12-27 4 FORM 4 SUBMISSION 0001209191-23-059828 9960
2023-11-14 4 FORM 4 SUBMISSION 0001209191-23-055219 5208
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054573 5166
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054569 5287
2023-11-01 S-8 S-8 0001193125-23-268267 333-275253 231368864 33 127562
2023-11-01 8-K HERBALIFE LTD. 8-K 2.02,7.01,9.01 0001157523-23-001598 001-32381 231368459 34 803788 1 1
2023-11-01 10-Q 10-Q 0000950170-23-057452 001-32381 231368424 34 16657114 1 1
2023-09-19 3 FORM 3 SUBMISSION 0001209191-23-050006 7938
2023-09-14 8-K HERBALIFE LTD. 8-K 5.02,9.01 0001157523-23-001416 001-32381 231255622 34 165218 1 1
2023-08-30 4 FORM 4 SUBMISSION 0001209191-23-047779 6987
2023-08-30 144 xsl144X01/primary_doc.xml 0001921094-23-000602 001-32381 231225526 33 4700
2023-08-08 4 FORM 4 SUBMISSION 0001209191-23-045094 7882
2023-08-08 4 FORM 4 SUBMISSION 0001209191-23-045092 7800
2023-08-02 10-Q 10-Q 0000950170-23-037182 001-32381 231135828 34 22442254 1 1
2023-08-02 8-K HERBALIFE LTD. 8-K 2.02,5.02,7.01,9.01 0001157523-23-001228 001-32381 231135793 34 709638 1 1
2023-07-10 3 FORM 3 SUBMISSION 0001209191-23-041966 10965
2023-07-10 3 FORM 3 SUBMISSION 0001209191-23-041964 16328
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028517 5346
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028097 12552
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028091 12439
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028086 9903
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028081 14365
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028076 9935
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028074 12328
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028072 9812
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028070 10594
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028068 9857
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028066 9847
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028063 9832
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028061 9828
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028058 9814
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028056 9838
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-028042 5191
2023-05-08 3 FORM 3 SUBMISSION 0001209191-23-028040 7946
2023-05-02 S-8 S-8 0001193125-23-132645 333-271586 23880376 33 104586
2023-05-02 10-Q 10-Q 0000950170-23-016715 001-32381 23879553 34 19709333 1 1
2023-05-02 8-K HERBALIFE NUTRITION LTD. 8-K 1.01,2.02,5.02,5.07,7.01,9.01 0001157523-23-000682 001-32381 23879235 34 597578 1 1
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024030 5085
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024028 5093
2023-03-27 DEFA14A DEFA14A 0001193125-23-080461 001-32381 23764711 34 14639
2023-03-14 ARS ARS 0001193125-23-070176 001-32381 23731357 34 1017635
2023-03-14 DEFA14A DEFA14A 0001193125-23-070174 001-32381 23731323 34 92499
2023-03-14 DEF 14A DEF 14A 0001193125-23-070170 001-32381 23731279 34 9322462 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016803 5080
2023-03-03 PRE 14A PRE 14A 0001193125-23-060161 001-32381 23705446 34 10198786 1 1
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013863 6960
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013853 5061
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013849 5082
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013842 5071
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013828 5058
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013821 5085
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-013005 5486
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012325 9393
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011903 11539
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011882 6840
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011872 6827
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011865 6851
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011857 11494
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011851 10617
2023-02-14 SC 13G b23230sc13g.htm 0001214659-23-002473 005-80216 23631302 34 69167
2023-02-14 10-K 10-K 0000950170-23-002787 001-32381 23629714 34 25972181 1 1
2023-02-14 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,7.01,8.01,9.01 0001157523-23-000278 001-32381 23629522 34 857648 1 1
2023-02-13 5 FORM 5 SUBMISSION 0001209191-23-008828 10781
2023-02-13 SC 13G/A hlf-13g_20221231.txt 0001037389-23-000019 005-80216 23615613 34 13628
2023-02-09 SC 13G MS INITIAL 0000895421-23-000108 005-80216 23604924 34 12885
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016120 005-80216 23603363 34 13270
2023-02-09 SC 13G/A filing.txt 0000315066-23-001768 005-80216 23603059 34 8453
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007890 11413
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007887 11499
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007884 11513
2023-02-07 SC 13G kyg4412g1010_020723.txt 0001306550-23-007916 005-80216 23593819 34 13696
2022-12-27 4 FORM 4 SUBMISSION 0001209191-22-062708 7711
2022-12-27 8-K 8-K 5.02,9.01 0001193125-22-312125 001-32381 221486881 34 314034 1 1
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060944 5227
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060940 5077
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060937 5088
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060932 5762
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060928 5091
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060924 7271
2022-12-13 4 FORM 4 SUBMISSION 0001209191-22-060920 5314
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060676 6276
2022-12-09 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-22-301866 001-32381 221455438 34 874717 1 1
2022-12-07 8-K 8-K 8.01,9.01 0001193125-22-299732 001-32381 221449062 34 180599 1 1
2022-12-05 8-K 8-K 8.01,9.01 0001193125-22-298436 001-32381 221445082 34 189817 1 1
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056602 5065
2022-11-03 4 xslF345X03/ownership.xml 0000919574-22-006219 23140
2022-11-03 3 xslF345X02/ownership.xml 0000919574-22-006218 13018
2022-10-31 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,5.02,7.01,9.01 0001157523-22-001444 001-32381 221346896 34 736211 1 1
2022-10-31 10-Q 10-Q 0000950170-22-020620 001-32381 221346566 34 18205276 1 1
2022-08-09 4 FORM 4 SUBMISSION 0001209191-22-045094 5041
2022-08-08 SC 13G/A SC 13G/A 0001193125-22-214879 005-80216 221144579 34 48692
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044346 4751
2022-08-02 3 FORM 3 SUBMISSION 0001209191-22-044005 16165
2022-08-02 3 FORM 3 SUBMISSION 0001209191-22-044003 13929
2022-08-02 3 FORM 3 SUBMISSION 0001209191-22-044001 9417
2022-08-02 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,5.02,7.01,9.01 0001157523-22-000997 001-32381 221129013 34 778408 1 1
2022-08-02 10-Q 10-Q 0000950170-22-013876 001-32381 221128981 34 17402080 1 1
2022-06-10 SC 13G/A SEC SCHEDULE 13G 0001422848-22-000249 005-80216 221008206 34 18453
2022-06-07 SC 13G/A herbalife13g2.htm 0000935836-22-000367 005-80216 22999122 34 89607
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031864 4752
2022-05-17 4 FORM 4 SUBMISSION 0001209191-22-029864 5283
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028605 5241
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028604 4806
2022-05-11 4 FORM 4 SUBMISSION 0001209191-22-028400 5928
2022-05-11 4 FORM 4 SUBMISSION 0001209191-22-028398 5460
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027845 5139
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027844 5072
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027842 5043
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027841 5127
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027839 5056
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027838 5072
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027836 5046
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027835 5058
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027834 5088
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027832 5049
2022-05-09 4 FORM 4 SUBMISSION 0001209191-22-027827 5030
2022-05-09 3 FORM 3 SUBMISSION 0001209191-22-027826 8449
2022-05-09 3 FORM 3 SUBMISSION 0001209191-22-027825 7819
2022-05-03 10-Q 10-Q 0000950170-22-007070 001-32381 22887142 34 13476587 1 1
2022-05-03 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,5.07,9.01 0001157523-22-000545 001-32381 22887049 34 612003 1 1
2022-04-18 DEFA14A DEFA14A 0001193125-22-108063 001-32381 22832523 34 2299765
2022-04-01 4 FORM 4 SUBMISSION 0001209191-22-021977 5735
2022-04-01 4 FORM 4 SUBMISSION 0001209191-22-021974 5057
2022-03-15 DEFA14A DEFA14A 0001193125-22-076048 001-32381 22741319 34 1006237
2022-03-15 DEF 14A DEF 14A 0001193125-22-076042 001-32381 22741258 34 3949490
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016334 5080
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014280 5129
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014277 5143
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014274 5133
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014262 5157
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014255 5156
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014249 5810
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014239 5131
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012427 8594
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012424 8607
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012421 8598
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012418 8622
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012414 8621
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012409 9275
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012406 8596
2022-02-23 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,8.01,9.01 0001157523-22-000242 001-32381 22663953 34 834805 1 1
2022-02-23 10-K 10-K 0000950170-22-001787 001-32381 22663886 34 23951139 1 1
2022-02-14 4 FORM 4 SUBMISSION 0001209191-22-009437 6851
2022-02-14 4 FORM 4 SUBMISSION 0001209191-22-009434 6836
2022-02-14 4 FORM 4 SUBMISSION 0001209191-22-009431 7056
2022-02-14 4 FORM 4 SUBMISSION 0001209191-22-009428 7716
2022-02-14 4 FORM 4 SUBMISSION 0001209191-22-009425 6826
2022-02-11 SC 13G/A hlf-13g_20211231.txt 0001037389-22-000144 005-80216 22621304 34 13620
2022-02-11 SC 13G/A SEC SCHEDULE 13G 0001422848-22-000192 005-80216 22618564 34 18522
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-019087 005-80216 22611983 34 13259
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017736 005-80216 22609954 34 13263
2022-02-09 SC 13G filing.txt 0000315066-22-000965 005-80216 22604322 34 8540
2022-02-08 SC 13G herbalife13g.htm 0000935836-22-000049 005-80216 22598841 34 90170
2021-12-10 SC 13G/A SEC SCHEDULE 13G 0001422848-21-000181 005-80216 211484834 34 18522
2021-12-09 SC 13G/A SCHEDULE 13G/A 0001104659-21-148061 005-80216 211481554 34 14127
2021-11-12 4 FORM 4 SUBMISSION 0001209191-21-064268 5062
2021-11-02 10-Q 10-Q 0000950170-21-002660 001-32381 211371561 34 16201383 1 1
2021-11-02 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,9.01 0001157523-21-001306 001-32381 211371494 34 785237 1 1
2021-09-20 4 FORM 4 SUBMISSION 0001209191-21-056892 5251
2021-09-13 8-K HERBALIFE NUTRITION LTD. 8-K 7.01,9.01 0001157523-21-001140 001-32381 211250565 34 199466 1 1
2021-08-17 4 FORM 4 SUBMISSION 0001209191-21-052037 4750
2021-08-09 4 FORM 4 SUBMISSION 0001209191-21-050398 4801
2021-08-09 4 FORM 4 SUBMISSION 0001209191-21-050396 4989
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050248 5093
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050247 5037
2021-08-06 3 FORM 3 SUBMISSION 0001209191-21-050246 9420
2021-08-03 10-Q 10-Q 0000950170-21-000713 001-32381 211140152 34 14969581 1 1
2021-08-03 8-K HERBALIFE NUTRITION LTD. 8-K 2.02,9.01 0001157523-21-000983 001-32381 211139966 34 762822 1 1
2021-07-30 8-K 8-K 1.01,9.01 0001193125-21-231587 001-32381 211133141 34 2062000 1 1
2021-05-26 4 FORM 4 SUBMISSION 0001209191-21-035908 5223
2021-05-21 8-K 8-K 1.02 0001193125-21-169419 001-32381 21950099 34 150550 1 1
2021-05-20 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-21-167805 001-32381 21944767 34 1159390 1 1
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031436 5297
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031433 5216
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031430 5228
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031428 5072
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031426 5043
2021-05-10 4 FORM 4 SUBMISSION 0001209191-21-031423 5056

Latest XBRL company facts

One latest value per concept from companyfacts (487 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 104.90M 2026-10-26 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
dei EntityPublicFloat Entity Public Float USD 762.00M 2025-06-30 2025 FY 10-K 2026-02-18 0001193125-26-057113
ecd TrdArrSecuritiesAggAvailAmt TrdArrSecuritiesAggAvailAmt shares 34,494 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335172
invest DerivativeNotionalAmount Derivative, Notional Amount USD 593.70M 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 93.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AccruedAdvertisingCurrent Accrued Advertising, Current USD 49.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 13.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 243.10M 2017-09-30 2017 Q3 10-Q 2017-11-02 0001564590-17-021220
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 58.70M 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 351,000 2011-06-30 2011 Q2 10-Q 2011-08-01 0000950123-11-071092
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.06B 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD 100,000 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD 10.40M 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD -215.50M 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -268.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 343.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AdditionsToNoncurrentAssets Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) USD 122.80M 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Other (Deprecated 2011-01-31) USD 751,000 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-02 0000950123-11-043005
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 10.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation USD 2.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -4.90M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-30 0001564590-18-025630
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 29.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 400,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap AdvertisingExpense Advertising Expense USD 42.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 29.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 7.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 9.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 300,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 9.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 800,000 2012-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 4.30M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap Assets Assets USD 2.89B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AssetsCurrent Assets, Current USD 1.23B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.20M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001564590-15-009169
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 3.40M 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 3.70M 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) USD 8.45M 2014-06-30 2014 Q2 10-Q 2014-07-28 0001193125-14-282448
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.10M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001564590-15-009169
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 2.60M 2011-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 10.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 7.70M 2012-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 100,000 2012-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap CapitalLeasesBalanceSheetAssetsByMajorClassNet Capital Leases, Balance Sheet, Assets by Major Class, Net USD 0 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 0 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 100,000 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 100,000 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation USD 7.40M 2012-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 409.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 434.80M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 432.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 56.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months USD -1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 7.75 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 500,000 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.3 2012-01-01 2012-03-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.3 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 2.00B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 104.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 104.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CommonStockValue Common Stock, Value, Issued USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 77.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 75.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ConvertibleDebt Convertible Debt USD 1.07B 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 893.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CreditCardReceivables Credit Card Receivables USD 69.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD -2.40M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 18.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 93.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 111.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 78.70M 2018-09-30 2018 Q3 10-Q 2018-10-30 0001564590-18-025630
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 1.83B 2014-09-30 2014 Q3 10-Q 2014-11-03 0001193125-14-394184
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 1.95B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 86.28 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 35.50M 2024-04-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 6.20M 2015-05-03 2015-05-04 2016 Q1 10-Q 2016-05-05 0001564590-16-018004
us-gaap DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Decrease in Unrecognized Tax Benefits is Reasonably Possible USD 8.10M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-267001
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 69.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DeferredCompensationPlanAssets Deferred Compensation Plan Assets USD 54.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -23.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 6.20M 2015-05-04 2018 Q2 10-Q 2018-08-01 0001564590-18-018480
us-gaap DeferredFinanceCostsNoncurrentGross Debt Issuance Cost, Gross, Noncurrent USD 5.70M 2012-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065327
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 21.50M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001564590-15-009169
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -38.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 453.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 4.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 123.40M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 39.30M 2020-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -2.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 163.60M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 905.60M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 5.00M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 445.40M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 568.80M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 113.50M 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 66.00M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022907
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 29.20M 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 25.60M 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 5.00M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 3.60M 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 37.20M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 46.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 132.90M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 22.50M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences USD 5.90M 2020-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.60M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 97.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 336.80M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 20.60M 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057452
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 69.40M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 20.90M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022907
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2.70M 2020-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap DeferredTaxLiabilitiesUndistributedForeignEarnings Deferred Tax Liabilities, Undistributed Foreign Earnings USD 16.10M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap Depreciation Depreciation USD 99.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 91.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeAssetFairValueGrossLiability Derivative Asset, Fair Value, Gross Liability USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeAssets Derivative Asset USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeAverageForwardExchangeRate Derivative, Average Forward Exchange Rate (Deprecated 2012-01-31) pure 0 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 6.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 9.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 2.90M 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap DerivativeLiabilities Derivative Liability USD 5.50M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DerivativeLiabilityFairValueGrossAsset Derivative Liability, Fair Value, Gross Asset USD 3.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap DividendIncomeOperating Dividend Income, Operating USD 3.40M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 30.40M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.528 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.055 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationFdiiAmount EffectiveIncomeTaxRateReconciliationFdiiAmount USD 8.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 6.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.056 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 27.00M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -18.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 140.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 86.40M 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057452
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) Y 1.8 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-30 0001193125-12-196239
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 5.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap EscrowDeposit Escrow Deposit USD 12.50M 2023-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 400,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 400,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 2.50M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 900,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 1.60M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 2.90M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.10M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 200,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 300,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 500,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 800,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 200,000 2019-09-30 2019 Q3 10-Q 2019-10-29 0001564590-19-038410
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 400,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 2.40M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.091 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FiniteLivedIntangibleAssetsAmortizationExpense Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) USD 600,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 300,000 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 100,000 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 100,000 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 100,000 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 400,000 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap FiniteLivedIntangibleAssetsUsefulLife Finite-Lived Intangible Assets, Useful Life (Deprecated 2012-01-31) Y 5 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap ForeignCurrencyExchangeRateRemeasurement Foreign Currency Exchange Rate, Remeasurement (Deprecated 2012-01-31) VEF/USD 5.3 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap ForeignCurrencyExchangeRateRemeasurement1 Foreign Currency Exchange Rate, Remeasurement pure 6.3 2014-06-30 2014 Q2 10-Q 2014-07-28 0001193125-14-282448
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 14.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 18.30M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-05 0001193125-15-172113
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 16.70M 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 21.40M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 100,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 300,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 600,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 300,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 400,000 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -94.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.30B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap Goodwill Goodwill USD 128.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 7.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 5.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 9.00M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap GoodwillTranslationAndPurchaseAccountingAdjustments Goodwill, Translation and Purchase Accounting Adjustments USD 12.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap GrossProfit Gross Profit USD 3.10B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -155.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 194.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 430.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 282.31M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-03 0001193125-14-394184
us-gaap IncomeTaxesPaid Income Taxes Paid USD 146.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 116.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 102.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 186.90M 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 2.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -15.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 30.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 57.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 3.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 15.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -5.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 4.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -15.50M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap IncreaseDecreaseInCustomerAdvances Increase (Decrease) in Customer Advances USD -11.10M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 3.00M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 22.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 31.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 26.30M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 25.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 24.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 40,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 310.00M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 331.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InterestExpense Interest Expense USD 116.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InterestExpenseDebt Interest Expense, Debt USD 123.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InterestIncomeDepositsWithFinancialInstitutions Interest Income, Deposits with Financial Institutions USD 8.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -116.30M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057452
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 100.70M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 205.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap InterestPayableCurrent Interest Payable, Current USD 40.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 403.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InventoryNet Inventory, Net USD 508.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 89.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 10.80M 2011-06-30 2011 Q2 10-Q 2011-08-01 0000950123-11-071092
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 15.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InventoryWriteDown Inventory Write-down USD 18.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 14.50M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 56.20M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap LeaseCost Lease, Cost USD 67.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 94.90M 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 243.90M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 67.00M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 46.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 24.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 29.60M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 33.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 42.20M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 5.20M 2019-09-30 2019 Q3 10-Q 2019-10-29 0001564590-19-038410
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 52.70M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 155.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap Liabilities Liabilities USD 3.29B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.89B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LineOfCredit Long-term Line of Credit USD 359.90M 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 893.80M 2014-06-30 2014 Q2 10-Q 2014-07-28 0001193125-14-282448
us-gaap LineOfCreditFacilityIncreaseAdditionalBorrowings Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) USD 500.00M 2012-07-01 2012-07-31 2012 FY 10-K 2013-02-19 0001193125-13-065327
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 700.00M 2011-03-09 2012 Q3 10-Q 2012-10-29 0001193125-12-439759
us-gaap LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party USD 1.50M 2025-04-08 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 12.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap LongTermDebt Long-term Debt USD 1.93B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 1.73B 2014-09-30 2014 Q3 10-Q 2014-11-03 0001193125-14-394184
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 100.00M 2014-09-30 2014 Q3 10-Q 2014-11-03 0001193125-14-394184
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 12.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 697.50M 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 12.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD 1.66B 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD 188.70M 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 27.80M 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 26.30M 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 22.00M 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 200,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 11.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 611.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 289.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.92B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 410.00M 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1.23B 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 5.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap MinorityInterestPeriodIncreaseDecrease Noncontrolling Interest, Period Increase (Decrease) USD 6.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -170.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -95.20M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010700
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -51.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -15.60M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010700
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 298.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 156.20M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010700
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 94.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NotionalAmountOfForeignCurrencyDerivatives Notional Amount of Foreign Currency Derivatives (Deprecated 2013-01-31) USD 610.10M 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap NotionalAmountOfInterestRateCashFlowHedgeDerivatives Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) USD 140.00M 2009-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap NumberOfCountriesInWhichEntityOperates Number of Countries in which Entity Operates Country 95 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NumberOfForeignCurrencyDerivativesHeld Number of Foreign Currency Derivatives Held Contract 0 2011-09-30 2011 Q3 10-Q 2011-10-31 0000950123-11-093523
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OciBeforeReclassificationsNetOfTaxAttributableToParent OCI, before Reclassifications, Net of Tax, Attributable to Parent USD -23.10M 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-03 0000950170-22-007070
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 405.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OperatingLeaseCost Operating Lease, Cost USD 66.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 15.80M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015356
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 191.20M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 37.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 145.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OperatingLeasePayments Operating Lease, Payments USD 55.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 161.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 253.70M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 43.10M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 12.50M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 23.00M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 27.40M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 36.30M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 111.40M 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005039
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.071 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 150.50M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 184.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -100,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent USD 3.20M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0000950170-21-002660
us-gaap OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0000950170-21-002660
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax (Deprecated 2012-01-31) USD 583,000 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-22 0000950123-11-016549
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 11.22M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-30 0001193125-12-196239
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -19.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) USD -3.09M 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent USD -1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax USD -1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 100,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD 6.70M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-03 0001564590-16-022354
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax USD 600,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax USD 200,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax USD -3.71M 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax USD -400,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -16.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesTax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Tax USD 800,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax USD 100,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-02 0000950170-21-002660
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) USD 700,000 2013-01-01 2013-03-31 2013 Q1 10-Q/A 2013-12-16 0001193125-13-474544
us-gaap OtherComprehensiveIncomeOtherNetOfTax Other Comprehensive Income, Other, Net of Tax USD -100,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD -1.72M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-30 0001193125-12-196239
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax USD 600,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0000950170-21-002660
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD -900,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 524.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 197.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherLongTermDebt Other Long-term Debt USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 10.50M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-07-31 0000950170-24-088605
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -94.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherOperatingIncome Other Operating Income USD 5.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 5.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities USD 2.30M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap PaymentsForDerivativeInstrumentFinancingActivities Payments for Derivative Instrument, Financing Activities USD 123.80M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 10.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 21.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 6.20M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 100,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 15.00M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 156.70M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 40.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PaymentsToAcquireRealEstate Payments to Acquire Real Estate USD 22.20M 2012-12-01 2012-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 3.80M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-26 0001193125-15-065723
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.002 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 7.50M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 194.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 55.90M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 785.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 1.90M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 1.42B 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 9.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 400,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013384
us-gaap ProceedsFromSaleOfRealEstate Proceeds from Sale of Real Estate USD 38.00M 2024-07-01 2024-07-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ProceedsFromSecuredNotesPayable Proceeds from Secured Notes Payable USD 800.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 91.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.51B 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 400.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 116.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 9.70M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-03 0001564590-16-022354
us-gaap ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent USD -8.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 747.90M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-10-31 0000950123-11-093523
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 1.92B 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 849.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 884.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RepaymentsOfUnsecuredDebt Repayments of Unsecured Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RestructuringCosts Restructuring Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RestructuringReserve Restructuring Reserve USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -485.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.99B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 21.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap SalesAllowancesGoods Sales Allowances, Goods (Deprecated 2018-01-31) USD 4.80M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-01 0001564590-18-018480
us-gaap SalesReturnsGoods Sales Returns, Goods (Deprecated 2018-01-31) USD 4.40M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 3.16B 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-02 0001564590-17-021220
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 2.46B 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-01 0001564590-18-018480
us-gaap SellingExpense Selling Expense USD 1.40B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.33B 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-267001
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 29.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 140,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 11.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 18.81 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 12.34 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 1.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 30.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 10.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.447 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-14 0000950170-23-002787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 24.80M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4.80M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap ShippingAndHandlingRevenue Shipping and Handling Revenue (Deprecated 2018-01-31) USD 227.40M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-22 0001564590-18-002880
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 7.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) USD 10.80M 2015-03-31 2015 Q1 10-Q 2015-05-05 0001193125-15-172113
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -409.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -403.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2 2018-04-24 2018 FY 10-K 2019-02-19 0001564590-19-003287
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 6.20M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 20.40M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 8.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000950170-25-023207
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 10.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 1.50B 2014-02-03 2014 Q2 10-Q 2014-07-28 0001193125-14-282448
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 1.50B 2021-02-09 2024 Q2 10-Q 2024-07-31 0000950170-24-088605
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) USD 814.20M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-04-28 0001193125-14-163119
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD 16.73M 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-22 0000950123-11-016549
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 17.70M 2012-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 29.50M 2018-10-01 2018-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 11.30M 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015356
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 69.02 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-04-28 0001193125-14-163119
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 10.00M 2021-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057452
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 10.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap TreasuryStockValue Treasury Stock, Value USD 328.90M 2021-12-31 2023 FY 10-K 2024-02-14 0000950170-24-015266
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 24.90M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 2.60B 2020-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 36.20M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 6.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 2.90M 2010-01-01 2010-12-31 2012 FY 10-K/A 2013-12-16 0001193125-13-474537
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 700,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 5.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 7.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 2.70M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002230
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 11.40M 2019-10-01 2019-12-31 2020 FY 10-K 2021-02-17 0001193125-21-046519
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 3.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 34.50M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 28.70M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 36.70M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap ValuationAllowancesAndReservesChargedToOtherAccounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account USD 1.60M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 2.10M 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-04-11 0001193125-12-158866
us-gaap VariableLeasePayment Variable Lease, Payment USD 4.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-057113
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 107.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 104.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443675
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 914,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-18 0001193125-14-057107

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →